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The patient characteristics of the three groups
CON NAV PSI
Gender (M:F) 7:23 4:26 13:17
Age (years) 69.8  8.5 67.0  7.3 67.5  8.2
Side (L:R) 17:13 12:18 14:16
Pre-operative mechanical
varus alignment (degrees)
13.5  6.8 13.2  5.6 13.6  6.6
Diagnosis (OA:RA) 27:3 28:2 29:1
Tourniquet times and operative times (minutes)
CON NAV PSI
Tourniquet
time
49.2  12.7
(33-87)
68.6  14.8
(42-100)
49.1  15.3
(28-87)
Operative
time
71.9  11.7
(51-110)
93.0  15.0
(59-120)
73.7  16.0
(51-117)
Outliers in component positions and lower limb alignment (%)
CON NAV PSI
Femoral component 23.3% 6.7% 16.7%
Coronal plane
Tibial component 20% 3.3% 6.6%
Coronal plane
Femoral component 56.7% 3.3% 13.3%*
Sagittal plane
Tibial component 13.3% 10% 20%
Sagittal plane
Lower limb alignment 53.3% 26.7% 30%
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S470in 84 knees and rheumatoid arthritis in 6 knees. The pre-operative
mechanical alignment of the lower limbwas in 13.46.3 (0-30) varus.
The knees were randomized in 1:1:1 ratio into one of the three groups -
conventional instruments (CON), computer navigation (NAV) and
patient speciﬁc instruments (PSI). They were also randomized with
regard to the 3 surgeons. Each surgeon performed 10 CON, 10 NAV and
10 PSI TKA. The three groups were matched, except there were more
male patients in the PSI group. The prostheses and surgical routines
were standardized. Post-operative standing long ﬁlms of the entire
lower limbs were taken.We recorded the tourniquet time and the
operative time (skin-to-skin). We measured the femoral and tibial
component positions in the coronal and axial planes and the overall
lower limb alignment of the lower limb after TKA.
Results: The mean tourniquet times were 49.212.7 minutes for CON,
68.614.8 minutes for NAV and 49.115.3 minutes for PSI groups (p <
0.001, Oneway ANOVA). Conventional instrument was more likely to
result in an excessively ﬂexed femoral component (p ¼ 0.001, Oneway
ANOVA). Number of outliers in postoperative lower limb alignment, and
other components positions in the coronal and sagittal plane showed no
statistically signiﬁcant difference.
Conclusion: We found that the tourniquet time and operation time of
using patient speciﬁc instrument in TKA were similar to that of con-
ventional instrument, and shorten than computer navigation. The post-
operative lower limb alignment and individual component positions
were similar in all 3 groups except in sagittal plane where conventional
instrument resulted in a signiﬁcantly ﬂexed femoral component.
Although statistical signiﬁcance was not achieved, the incidence of
outliers was the highest in the conventional instrument group, followed
by patient speciﬁc instrument and ﬁnally computer navigation. The
current studied identiﬁedmarginal beneﬁt of PSI in isolated component
position compared to conventional instrument. A prospective study
with a larger sample size and better post-op imaging modality (e.g. CT
or MRI) may be needed to prove the efﬁcacy of PSI.860
MRI-DETECTED OSTEOPHYTE IS A PREDICTOR FOR RECEIVING
TOTAL KNEE ARTHROPLASTY IN PATIENTS WITH END-STAGE KNEE
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Purpose: For physicians, objective indicators which represent the past
results of patients already received total knee arthroplasty (TKA) are
helpful to discuss with patients who are considering the decision to
TKA. The decisionwhether to have a TKA or not for patients with severe
knee osteoarthritis (OA) is ambiguous, and it has to take account of a
disability of the patient, in addition to X-ray changes. However, radi-
ography is relatively insensitive, and it only provides a historical view of
the skeletal damage that has already occurred. Magnetic resonance
imaging (MRI) has potential to overcome these limitations of radiog-
raphy and therefore holds the greatest potential as a tool for whole-
organ imaging of the joint. In our previous study the radiographic OA
severity did not predict the risk for receiving TKA due to their low
sensitivity and speciﬁcity, while the disability of daily living evaluated
by the patient-oriented outcome measure for knee OA did (Liu et al,
JBMM 2013). The aim of this study was to examine whether the OA
severity evaluated by MRI can predict the risk for receiving TKA.
Methods: This study protocol was approved by the institutional review
board of our university. 135 painful medial knee OA patients with Kel-
legren-Laurence (K/L) grade 4 were enrolled in this study. The subjects
were all instructed to perform therapeutic exercise by physician and
conducted the therapeutic exercise for 6months. Radiographic ﬁndings,
visual analog scale for pain and a patient-oriented outcome measure,
the Japanese Knee Osteoarthritis Measure (JKOM), were recorded at
baseline. All subjects underwent 1.5-Tesla knee MRI between 1 and 7
days after the day that standing knee radiographs taken. MRI scans
were read using a standardized and validatedmethod called the whole-
organ MRI scoring method (WORMS), which is consisted of the speciﬁc
features related to OA, as below; [1] cartilage morphology, [2] bone
marrow lesions (BMLs), [3] bone cysts, [4] bone attrition, [5] meniscal
pathology and [6] osteophytes. Each parameter was semi-quantitatively
scored with good reproducibility. The signiﬁcant differences of the data
between TKA and non-TKA groups were evaluated using the Mann
Whitney-U test. The area under the ROC curve (AUC) was estimated for
the discriminative value of prediction models. The criteria for accepting
the null hypothesis were AUCs <0.70. Relative risk (RR) was calculated
to evaluate the cut-off score of WORMS score for receiving TKA. Cor-
relations between the score evaluated by MRI with either the pain VAS
score or the JKOM score were examined using Spearman’s rank corre-
lation coefﬁcient.
Results: As 7 of 135 patients who were able to be followed up (5.2%)
were excluded from the study during follow-up, remaining 128 patients
were subjected to the analysis. While 74 of the 128 patients (57.8%) did
not receive TKA (non-TKA group), the remaining 54 patients (42.2%)
underwent TKA (TKA group) during the 6 months from the baseline
even though they performed therapeutic home exercise.
The WORMS total score (166.8/332), total cartilage morphology score
(80.4/84), BML score (11.6/45), osteophytes score (37.8/98) of TKA group
were signiﬁcantly increased in comparison to those of non-TKA group
(WORMS total score; 150.6/332, p < 0.01), (total cartilage morphology
score; 79.1/84, p < 0.01), (BML score; 8.8/45, p < 0.01), (osteophytes
score; 29.6/98, p < 0.001), respectively. In contrast, no signiﬁcant dif-
ferences of bone cyst score and bone attrition score were observed
between TKA group and non-TKA group. Among the WORMS sub-cat-
egories, the osteophytes scores was only correlated with the JKOM total
score (r¼ 0.19, p< 0.05). The AUC in ROC curve of cartilage morphology,
BML and osteophyte scores were 0.64 (95% CIs; 0.54 to 0.74), 0.64 (95%
CIs; 0.54 to 0.74), and 0.72 (95% CIs; 0.64 to 0.81), respectively. The cut-
off of osteophyte score calculated by ROC curve was found at 30 point
and the RR at 30 point of osteophyte score for receiving TKA was 3.01
(95% CIs; 1.39 to 6.52).
Conclusions: The osteophyte score is signiﬁcantly associated with the
scores for disability in daily living of patients with knee OA. The
osteophyte score, in addition to the scores for disability in daily living,
Figure 1) Representative micrographs of the medial tibial plateau (bot-
tom) and medial femoral condyle (top) from study # 3. 50X original
magniﬁcation
Figure 2) Quantitation of the effects of rhGDF5 intra-articular therapy on
signiﬁcant cartilage lesion width of the medial tibial plateau. Day 21
untreated group indicates the extent of cartilage erosion present at the
onset of therapy. Data represent 15 rats/group from study # 3.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S471were revealed to be more predictive of a patient receiving TKA than the
other scores. Osteophyte, at least in patients with end-stage knee OA,
may induce disability of daily living, associating the determination of
the patients for receiving TKA. In conclusion, when we evaluate the
structural changes due to knee OA by MRI, osteophytes score is only a
predictor for receiving TKA.
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THE RESULTS OF MODIFIED DISTRACTION ARTHROPLASTY FOR
DEGENERATED OSTEOARTHRITIS OF THE ANKLE
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Shoe Disorders, Tokyo, Japan; zDept. of Orthpedic Surgery, Keio Univ.,
Tokyo, Japan
Purpose: In the treatment of degenerated osteoarthritis of the ankle,
we obtained good results in terms of preserving the joint functions and
relieving pain by performing a procedure to reconstruct the anatomical
structure of the ankle, accompanied by ROM exercises undertaken with
the joint space kept pulled apart with a conventionally used external
ﬁxator.
Methods: A total of 43 patients (45 ankles; 28 ankles in 28 male
patients and 17 ankles in 15 female patients) who underwent the
procedure from 1998 to 2012 were enrolled in the study. The patients
were 18-72 years old, with a mean age of 56 years at the time of the
procedure. In regard toTakakura’s classiﬁcation, 6 ankles were classiﬁed
as Stage 2, 21 as Stage 3a, 12 as Stage 3b, and 6 as Stage 4. The patients
underwent debridement by the conventional method, including
removal of bone spurs and synovectomy, combined with low tibial
osteotomy, osteochondral graft, drilling and/or reconstruction of ankle
lateral ligaments. As post-treatment, patients were started on active
ROM exercises from the day after the surgery and started partial weight
bearing at 6-8 weeks after the surgery. The external ﬁxation device was
removed to allow total weight bearing at 3 months. Follow-ups were
performed for 1-8 years, with a mean of 4 years and 7 months.
Results: The pain severity did not change in 2 ankles. For the remaining
43 ankles in which the pain improved, no problems in daily life activ-
ities, but inability to undertake sports activities were observed for 31
ankles, while no problems in either physical work or sporting activities
for 12 ankles. None of the patients took painkiller. Improvements of the
ROMwere seen in 10 ankles, while no change of the ROMwas observed
in the remaining 35 ankles. There were no patients who needed addi-
tional operations such as arthrodesis during the follow-up period.
Conclusions: Procedures such as arthrodesis, total ankle replacement
and low tibial osteotomy are performed to treat degenerated osteo-
arthritis of the ankle, but each of these is associated with problems,
including those related to the qualifying age, durability, and range of
motion. It is difﬁcult to select a proper treatment option, especially for
relatively young patients. In contrast, there is no age requirement for
the procedure described in this study, because joint functions are pre-
served by restoring the patients’ own tissue and the patients suffered
only mild postoperative limitation of the ADL. As demerits, this pro-
cedure is less effective for pain relief than arthrodesis and more
abundant experience is required, because several kinds of surgical
procedures have to be performed. However, it can be indicated for
young patients in whom preservation of the joint functions and higher
activity potential are required. In addition it is well applicable to
degenerated osteoarthritis of the ankle that arises at a relatively early
age, because future joint replacement or arthrodesis will not be difﬁcult
in patients who undergo this procedure.
Therapy- Intraarticular
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INTRA-ARTICULAR SUPPLEMENTATION WITH RECOMBINANT
HUMAN GDF5 ARRESTS DISEASE PROGRESSION AND STIMULATES
CARTILAGE REGENERATION IN THE RAT MEDIAL MENISCUS
TRANSECTION (MMT) MODEL OF OSTEOARTHRITIS
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A.M. Bendele x, B.J. Story y. yDePuy Synthes Mitek Sports Med., Raynham,
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Purpose: Genome-wide association studies and investigation of
osteoarthritis (OA) risk alleles suggest that reduced levels of functional
Growth and Differentiation Factor 5 (GDF5) expression in tissues of the
joint may be a precipitating factor contributing to OA. Therefore, wehypothesized that supplementation of rhGDF5 to the OA joint via intra-
articular injection may represent a viable therapeutic approach.
Methods: We used a rat medial meniscus transection (MMT) model of
OAwhich causes rapid and progressive OA-like pathology including the
aggressive erosion of articular cartilage. Three studies were conducted
(n ¼ 15 / treatment group) to investigate the feasibility of rhGDF5 in
either a preventative or therapeutic modality: (1) 6 weekly injections
beginning on day 3 post MMT with termination on day 42 (pre-
ventative), (2) 6 weekly or 3 bi-weekly injections beginning on day 21
post MMT with termination on day 63 (therapeutic), and 3) a single
injection, or a series of 2 or 3 bi-weekly injections, beginning on day 21,
with termination on day 63 (therapeutic). rhGDF5 doses ranging from
0.3 to 100 mg were studied, using a glycine buffered trehalose vehicle
(pH¼3.0). Joints were harvested and processed for histological analysis
following toluidine blue staining. Quantitative and semi-quantitative
histopathological end points were used to evaluate the extent of OA
progression in the medial tibial plateau cartilage.
Results: rhGDF5 demonstrated signiﬁcant dose-dependent cartilage
protection as a preventative therapy (Study 1). In particular, the width
of signiﬁcant tibial lesions was reduced by 11% by repeat treatment with
0.3 mg rhGDF5, 22% by 3 mg, 32% by 10 mg, and 49% by 30 mg injections
when compared with vehicle controls. Study 2 demonstrated dose-
dependent efﬁcacy of rhGDF5 compared with vehicle controls when
administered in a therapeutic modality beginning on day 21 post MMT.
Following 6 weekly injections, the width of signiﬁcant tibial lesions was
reduced by 30% by a 10 mg rhGDF5 dose and by 47% by a 30 mg dose.
